Literature DB >> 1245486

External labeling of human erythrocyte glycoproteins. Studies with galactose oxidase and fluorography.

C G Gahmberg.   

Abstract

Glycoproteins of the human erythrocyte membrane were labeled with tritiated sodium borohydride after oxidation of terminal galactosyl and N-acetylgalactosaminyl residues with galactose oxidase. After separation of the polypeptides on polyacrylamide slab gels, a scintillator was introduced into the gel, and the radioactive proteins were visualed by autoradiography (fluorography). The following results were obtained. (a) The erythrocyte membrane contains at least 20 glycoproteins, many of which are minor components. (b) The carbohydrate of all the labeled glycoproteins is exposed only to the outside, since no additional glycoproteins can be labeled in isolated unsealed ghosts. (c) The membrane contains two major groups of glycoproteins. The first group of proteins contains sialic acids linked to the penultimate galactosyl/N-acetylgalactosaminyl residues, which are efficiently labeled only after pretreatment with neuraminidase. The second group has terminal galactosyl/N-acetylgalactosaminyl residues which can be easily labeled without neuraminidase treatment. The glycoproteins from fetal erythrocytes all belong to the first group, whereas only five glycoproteins of erythrocytes from adults belong. (d) Trypsin cleaves the proteins containing sialic acids, and fragments containing carbohydrate remain tightly bound and exposed in the membrane. (e) Pronase cleaves Band 3 in addition to the sialic acid containing glycoproteins, but most of the glycoproteins still remain unmodified in the membrane. (f) No difference is seen between membrane glycoproteins from cells of different ABH blood groups.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1245486

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Identification of differences between the surface proteins and glycoproteins of normal mouse (Balb/c) and human erythrocytes.

Authors:  R J Howard; P M Smith; G F Mitchell
Journal:  J Membr Biol       Date:  1979-08       Impact factor: 1.843

Review 2.  Carbohydrate analysis of glycoproteins. A review.

Authors:  K B Lee; D Loganathan; Z M Merchant; R J Linhardt
Journal:  Appl Biochem Biotechnol       Date:  1990-01       Impact factor: 2.926

3.  Cross-linking of erythrocyte membrane proteins by periodate and intramembrane particle distribution.

Authors:  C G Gahmberg; I Virtanen; J Wartiovaara
Journal:  Biochem J       Date:  1978-06-01       Impact factor: 3.857

4.  Abnormality of glycophorin-alpha on paroxysmal nocturnal hemoglobinuria erythrocytes.

Authors:  C J Parker; C M Soldato; W F Rosse
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Pj variant, a new hybrid MNSs glycoprotein of the human red-cell membrane.

Authors:  D Blanchard; J P Cartron; P Rouger; C Salmon
Journal:  Biochem J       Date:  1982-05-01       Impact factor: 3.857

6.  External labelling of glycoproteins from first-trimester human placental microvilli.

Authors:  S J Fisher; M S Leitch; R A Laine
Journal:  Biochem J       Date:  1984-08-01       Impact factor: 3.857

7.  Gel electrophoresis of the human erythrocyte membrane proteins: aberrant patterns in hematological and non-hematological diseases.

Authors:  V Anselstetter
Journal:  Blut       Date:  1978-03-15

8.  Surface glycoproteins of resting and activated human T lymphocytes.

Authors:  L C Andersson; C G Gahmberg
Journal:  Mol Cell Biochem       Date:  1979-10-15       Impact factor: 3.396

9.  The glycoprotein of measles virus. External radioactive labelling of its carbohydrate and partial characterization of the glycopeptide.

Authors:  O Anttonen; M Jokinen; A Salmi; R Vainionpää; C G Gahmberg
Journal:  Biochem J       Date:  1980-01-01       Impact factor: 3.857

10.  ABO(H) blood group antigens of the human erythrocyte membrane: contribution of glycoprotein and glycolipid.

Authors:  N G Mehta
Journal:  J Membr Biol       Date:  1980-01-31       Impact factor: 1.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.